Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com
Stock analysts at StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the medical research company’s stock. Several other research analysts also recently commented on the company. D. Boral Capital reaffirmed a “buy” rating and set a […]
Stock analysts at StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the medical research company’s stock. Several other research analysts also recently commented on the company. D. Boral Capital reaffirmed a “buy” rating and set a […]
